MiR-124 sensitizes cisplatin-induced cytotoxicity against CD133(+) hepatocellular carcinoma cells by targeting SIRT1/ROS/JNK pathway

Drug resistance is still a major obstacle for efficient treatment of hepatocellular carcinoma (HCC) during the cisplatin-based chemotherapy. Recent studies have demonstrated that CD133 positive population of cancer cells are responsible for multiple drug resistance. We are supposed to take strategie...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Yunxiuxiu, Lai, Yu, Weng, Hanqin, Tan, Lanping, Li, Yanshan, Chen, Guangcheng, Luo, Xingxi, Ye, Yibiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535064/
https://www.ncbi.nlm.nih.gov/pubmed/31056532
http://dx.doi.org/10.18632/aging.101876

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535064/
https://www.ncbi.nlm.nih.gov/pubmed/31056532
http://dx.doi.org/10.18632/aging.101876

Ejemplares similares